A cutting-edge technological platform combined with an expertise in biophysics and biology to offer you unique support in accomplishment of your projects
A TEAM AND TOOLS DEDICATED TO YOUR R&D PROBLEMS
One of the main challenges in development of new therapies is to understand the biological mechanisms involved in pathologies. The solution developed by BioMeca in pharmacology helps you to understand these action’s mechanisms and reveals the therapeutic effect of your molecules and products.
Light on our solutions
Tumor escape and extracellular matrix
A new dependence receptors family (DR) has been discovered by one of our academic partner. These receptors inhibit tumor progression by inducing apoptosis when cancer cells are in absence of DR ligands. Due to the frequent inactivation of their apoptotic function in human cancers, DRs are now considered as tumor suppressors.
The main barrier of the skin is located in the outermost layer of the skin, the stratum corneum. Several damages in stratum corneum involve skin barrier disorders as Atopic Dermatitis, compex disease due to multiple factors (immunologic, genetic, environnemental). During formation of the stratum corneum barrier, terminally differentiated keratinocytes continue their maturation process within the dead superficial epidermal layer.
Pancreatic ductal adenocarcinoma (PDAC) is the fourth most frequent cause of cancer-related deaths worldwide and should become the second one hence 2030. The extracellular matrix (ECM) in the tumor microenvironment modulates the cancer cell phenotype, especially in pancreatic ductal adenocarcinoma (PDAC), a tumor characterized by an intense desmoplastic reaction. PDAC is characterized by an intense “desmoplastic reaction”, consisting of the abnormal accumulation of ECM components, mostly collagen fibers.